Cargando…

Systematic characterization of non‐coding RNAs in triple‐negative breast cancer

Triple‐negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer with negativity for oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER2). Non‐coding RNAs (ncRNAs) make up most of the transcriptome and are widely present in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mei, Jie, Hao, Leiyu, Wang, Huiyu, Xu, Rui, Liu, Yan, Zhu, Yichao, Liu, Chaoying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260065/ https://www.ncbi.nlm.nih.gov/pubmed/32249490 http://dx.doi.org/10.1111/cpr.12801

Ejemplares similares

Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer
por: Mei, Jie, et al.
Publicado: (2019)

Correction: Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer
por: Mei, Jie, et al.
Publicado: (2023)

The Landscape of Small Non-Coding RNAs in Triple-Negative Breast Cancer
por: Guo, Yan, et al.
Publicado: (2018)

Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer
por: Aranza-Martínez, Alberto, et al.
Publicado: (2021)

Roles and expression profiles of long non‐coding RNAs in triple‐negative breast cancers
por: Kong, Xiangyi, et al.
Publicado: (2017)

Identification of novel long non-coding RNAs in triple-negative breast cancer
por: Shen, Xiaokun, et al.
Publicado: (2015)

Characterization of the expression and prognostic value of 14-3-3 isoforms in breast cancer
por: Mei, Jie, et al.
Publicado: (2020)

Correction for: Characterization of the expression and prognostic value of 14-3-3 isoforms in breast cancer
por: Mei, Jie, et al.
Publicado: (2022)

Blood Circulating Non-Coding RNAs for the Clinical Management of Triple-Negative Breast Cancer
por: Powrózek, Tomasz, et al.
Publicado: (2022)

Recent Clinical Advances on Long Non-Coding RNAs in Triple-Negative Breast Cancer
por: Singh, Desh Deepak, et al.
Publicado: (2023)

Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment
por: Palcau, Alina Catalina, et al.
Publicado: (2023)

Mechanistic Involvement of Long Non-Coding RNAs in Oncotherapeutics Resistance in Triple-Negative Breast Cancer
por: Kansara, Samarth, et al.
Publicado: (2020)

The interplay between HIF-1α and noncoding RNAs in cancer
por: Peng, Xiafeng, et al.
Publicado: (2020)

Identification of long non-coding RNA signatures in triple-negative breast cancer
por: Tian, Tian, et al.
Publicado: (2018)

Correction to: The interplay between HIF-1α and noncoding RNAs in cancer
por: Peng, Xiafeng, et al.
Publicado: (2020)

Secreted Non-Coding RNAs: Functional Impact on the Tumor Microenvironment and Clinical Relevance in Triple-Negative Breast Cancer
por: Di Agostino, Silvia, et al.
Publicado: (2022)

Integrative analysis of lncRNAs and miRNAs with coding RNAs associated with ceRNA crosstalk network in triple negative breast cancer
por: Yuan, Naijun, et al.
Publicado: (2017)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016)

A ten N6‐methyladenosine‐related long non‐coding RNAs signature predicts prognosis of triple‐negative breast cancer
por: Wu, Jie, et al.
Publicado: (2021)

The emerging roles of circular RNAs in ovarian cancer
por: Yang, Xuejing, et al.
Publicado: (2020)

The long non‐coding RNA landscape in triple‐negative breast cancer
por: Zhang, Wenwen, et al.
Publicado: (2020)

THU492 Functional Characterization Of Nuclear-enriched Non-coding Genes In Triple-negative Breast Cancer
por: Reid, Victoria A, et al.
Publicado: (2023)

Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis
por: Zhang, Shuo, et al.
Publicado: (2020)

MicroRNAs and Triple Negative Breast Cancer
por: D’Ippolito, Elvira, et al.
Publicado: (2013)

Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer
por: Rodríguez Bautista, Rubén, et al.
Publicado: (2018)

MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction with Clinical Outcome
por: Medimegh, Imen, et al.
Publicado: (2014)

The Missing Lnc: The Potential of Targeting Triple-Negative Breast Cancer and Cancer Stem Cells by Inhibiting Long Non-Coding RNAs
por: Brown, Justin M, et al.
Publicado: (2020)

Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression
por: Sha, Sha, et al.
Publicado: (2017)

Correction to: Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer
por: Bautista, Rubén Rodríguez, et al.
Publicado: (2018)

Phenotype–genotype network construction and characterization: a case study of cardiovascular diseases and associated non-coding RNAs
por: Wu, Rongrong, et al.
Publicado: (2020)

Long non‑coding RNA PTCSC3 suppresses triple‑negative breast cancer by downregulating long non‑coding RNA MIR100HG
por: Zhang, Guojun, et al.
Publicado: (2023)

Transcriptional alterations of protein coding and noncoding RNAs in triple negative breast cancer in response to DNA methyltransferases inhibition
por: Elango, Ramesh, et al.
Publicado: (2021)

Identification of Long Noncoding RNAs as Predictors of Survival in Triple-Negative Breast Cancer Based on Network Analysis
por: Li, Xiao-Xiao, et al.
Publicado: (2020)

Characterization of the Clinical Significance of PD-1/PD-Ls Expression and Methylation in Patients With Low-Grade Glioma
por: Mei, Jie, et al.
Publicado: (2021)

Systematic Identification and Characterization of Long Non-Coding RNAs in the Silkworm, Bombyx mori
por: Wu, Yuqian, et al.
Publicado: (2016)

Systematic characterization and biological functions of non‐coding RNAs in glioblastoma
por: Dai, Lirui, et al.
Publicado: (2022)

YWHAZ interacts with DAAM1 to promote cell migration in breast cancer
por: Mei, Jie, et al.
Publicado: (2021)

MicroRNAs in regulation of triple-negative breast cancer progression
por: Piasecka, Dominika, et al.
Publicado: (2018)

Circulating non-coding RNA-biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
por: Ritter, Andrea, et al.
Publicado: (2019)

Long Non Coding RNA in Triple Negative Breast Cancer: A Promising Biomarker in Tumorigenesis
por: Nandagopal, Srividhya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g1usnc949p7aog3e2p2vt3s24g